Infigratinib is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities.
Product Details
| Alternative Name: | BGJ-398 |
| |
| Formula: | C26H31CI2N7O3 |
| |
| MW: | 560.5 |
| |
| CAS: | 872511-34-7 |
| |
| Purity: | ≥99% (HPLC) |
| |
| Appearance: | White solid. |
| |
| Solubility: | Soluble in DMSO. |
| |
| Shipping: | Blue Ice |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
